A Pellegrini

ORCID: 0000-0003-1179-809X · 2 papers in corpus
article 2012
M193 SINGLE OR REPEATED GNRH AGONIST TREATMENT AVOIDS HYSTERECTOMY IN PREMENOPAUSAL WOMEN WITH LARGE SYMPTOMATIC FIBROIDS WITH NO EFFECTS ON SEXUAL FUNCTION
·doi:10.1016/s0020-7292(12)61387-3
article 2000
Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/s0301-2115(99)00131-1

ObjectiveThis is a randomized clinical trial comparing estroprogestin (E/P) pill given for 12 months vs. gonadotrophin releasing hormone agonist (GNRHa) given for 4 months followed by E/P pill treatment for 8 months in the relief of endomet…